
307: More tumult at BIO & coercive care for sickle cell patients
The Readout Loud
00:00
Management Shake-up and Industry Challenges at Bio
The chapter delves into a major internal restructuring at Bio, led by new CEO John Crowley, resulting in the dismissal of key personnel. It also explores the organization's initiatives under Crowley's leadership, including programs for women's health, while addressing industry challenges such as the Inflation Reduction Act and its impact on patent protection.
Transcript
Play full episode